A highly sensitive 3baseTM assay for detecting Streptococcus pyogenes in saliva during controlled human pharyngitis

Anuk D. Indraratna,Sacha Mytton,Alison Ricafrente,Doug Millar,Jody Gorman,Kristy I. Azzopardi,Hannah R. Frost,Joshua Osowicki,Andrew C. Steer,Danielle Skropeta,Martina L. Sanderson-Smith
DOI: https://doi.org/10.1016/j.talanta.2024.126221
IF: 6.1
2024-05-23
Talanta
Abstract:Streptococcus pyogenes (Group A Streptococcus; GAS) is a Gram-positive bacterium responsible for substantial human mortality and morbidity. Conventional diagnosis of GAS pharyngitis relies on throat swab culture, a low-throughput, slow, and relatively invasive 'gold standard'. While molecular approaches are becoming increasingly utilized, the potential of saliva as a diagnostic fluid for GAS infection remains largely unexplored. Here, we present a novel, high-throughput, sensitive, and robust speB qPCR assay that reliably detects GAS in saliva using innovative 3baseTM technology (Genetic Signatures Limited, Sydney, Australia). The assay has been validated on baseline, acute, and convalescent saliva samples generated from the C ontrolled H uman I nfection for V accination A gainst S treptococcus (CHIVAS-M75) trial, in which healthy adult participants were challenged with emm75 GAS. In these well-defined samples, our high-throughput assay outperforms throat culture and conventional qPCR in saliva respectively, affirming the utility of the 3baseTM platform, demonstrating the feasibility of saliva as a diagnostic biofluid, and paving the way for the development of novel non-invasive approaches for the detection of GAS and other oropharyngeal pathogens.
chemistry, analytical
What problem does this paper attempt to address?